logo

For the Inventor, By the Inventor

Boxmeer, Netherlands

Intervet International B.v.


USPTO Granted Patents = 107

% Expired Patents = 40.2



Trademarks = 25

Forward Citations = 293

Loading Chart...
Loading Chart...

216 inventors (with patents filed for the assignee):

goldMedal Paul Vermeij (8 out of 16 patents)

silverMedal Antonius Arnoldus Christiaan Jacobs (8 out of 28 patents)

bronzeMedal Ruud Philip Antoon Maria Segers (6 out of 13 patents)

4.  Carla Christina Schrier (6 out of 28 patents)

5.  Thorsten Meyer (5 out of 5 patents)

6.  Melissa Anne Lum (4 out of 9 patents)

7.  Christophe Pierre Alain Chassaing (4 out of 10 patents)

8.  Hans Almer Middelbeek (4 out of 5 patents)

9.  Ralf Warrass (4 out of 4 patents)

10.  Fritz Blatter (3 out of 58 patents)

11.  Daniel Ghislena Emiel Goovaerts (3 out of 8 patents)

12.  Mark William Mellencamp (3 out of 15 patents)

13.  Stephane Villoing (3 out of 5 patents)

14.  Jozefus A C Smit (3 out of 4 patents)

15.  Frank J Sterner (3 out of 3 patents)


Core Competencies:
Anthelmintic Agents
Vaccine Formulations
Macrolide Synthesis
Recombinant Viruses
Injectable Compositions
Inactivated Vaccines
Bacterium Vaccines
Fish Vaccine
Coccidiosis Vaccines
Thyroid Hormone Composition
Zilpaterol Salts
Respiratory Disease Control

107 patents:

1. 12710423 - AFRICAN SWINE FEVER DIVA IMMUNOASSAY (2026-08-18),
2. 12697381 - BACULOVIRUS EXPRESSION VECTOR (2026-08-04),
3. 12661395 - Canine Parvovirus (2026-06-23),
4. 9198963 - [object Object] (2015-12-01),
5. 9119794 - Process to form a tablet and apparatus suitable for applying this process (2015-09-01),
6. 9096524 - Anthelmintic agents and their use (2015-08-04),
7. 9084768 - [object Object] (2015-07-21),
8. 9051557 - [object Object] (2015-06-09),
9. 8968744 - Aqueous composition comprising a biological antigen and an acrylic acid polymer (2015-03-03),
10. 8961485 - Method and equipment for fastening a thread to a tampon (2015-02-24),
11. 8911744 - Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV (2014-12-16),
12. 8802378 - Potency test for vaccine formulations (2014-08-12),
13. 8778868 - Chemically defined vaccine stabiliser (2014-07-15),
14. 8777134 - Suspension comprising benzimidazole carbamate and a polysorbate (2014-07-15),
15. 8763446 - Tube weld steam test device and method (2014-07-01),
Company Overview
Intervet International B.V., headquartered in Boxmeer, Netherlands, specializes in the development and manufacture of veterinary vaccines. The company focuses on a range of core technology topics, including anthelmintic agents, vaccine formulations, and the synthesis of macrolides. Intervet is dedicated to advancing veterinary medicine through innovative solutions such as recombinant viruses, injectable compositions, and both inactivated and bacterium vaccines, catering to various animal health needs across global markets.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Intervet International B.v. USPTO Patent Assignee Logo
107 Patents

#2 in Boxmeer

#82 in Netherlands

#7,342 in the World

Boxmeer, NL
Boxmeer, Netherlands

Intervet International B.v.

Forward Citations = 293

216 inventors:

goldMedal Paul Vermeij (8 out of 16 patents)

silverMedal Antonius Arnoldus Christiaan Jacobs (8 out of 28 patents)

bronzeMedal Ruud Philip Antoon Maria Segers (6 out of 13 patents)

4.  Carla Christina Schrier (6 out of 28 patents)

5.  Thorsten Meyer (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Intervet International B.v.. Retrieved from https://idiyas.com/company/intervet-international-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…